PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Amlodipine
Presentation Product Chemical substance Chapter Items dispensed
Amlodipine 5mg tablets
0206020A0AAAAAA
Amlodipine Amlodipine Cardiovascular System 2,915,487
Amlodipine 10mg tablets
0206020A0AAABAB
Amlodipine Amlodipine Cardiovascular System 2,489,122
Amlodipine 2.5mg tablets
0206020A0AAAVAV
Amlodipine Amlodipine Cardiovascular System 92,062
Istin 5mg tablets
0206020A0BBAAAA
Istin Amlodipine Cardiovascular System 6,185
Istin 10mg tablets
0206020A0BBABAB
Istin Amlodipine Cardiovascular System 5,397
Amlodipine 5mg/5ml oral solution sugar free
0206020A0AAALAL
Amlodipine Amlodipine Cardiovascular System 4,507
Amlodipine 10mg/5ml oral solution sugar free
0206020A0AAATAT
Amlodipine Amlodipine Cardiovascular System 1,584
Amlodipine 5mg/5ml oral suspension sugar free
0206020A0AAAUAU
Amlodipine Amlodipine Cardiovascular System 1,550
Amlodipine 5mg/5ml oral liquid
0206020A0AAACAC
Amlodipine Amlodipine Cardiovascular System 52
Amlodipine 10mg/5ml oral liquid
0206020A0AAADAD
Amlodipine Amlodipine Cardiovascular System 14
Amlostin 5mg tablets
0206020A0BFAAAA
Amlostin Amlodipine Cardiovascular System 2
Amlodipine 1.5mg/5ml oral liquid
0206020A0AAAMAM
Amlodipine Amlodipine Cardiovascular System 1
Amlodipine 2.5mg/5ml oral suspension
0206020A0AAAJAJ
Amlodipine Amlodipine Cardiovascular System No data available
Amlodipine 2mg/5ml oral liquid
0206020A0AAANAN
Amlodipine Amlodipine Cardiovascular System No data available
Amlodipine 4mg/5ml oral liquid
0206020A0AAAGAG
Amlodipine Amlodipine Cardiovascular System No data available
Amlodipine 50mg/5ml oral liquid
0206020A0AAAFAF
Amlodipine Amlodipine Cardiovascular System No data available
Amlostin 10mg tablets
0206020A0BFABAB
Amlostin Amlodipine Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.